Dataset Information
Sodium channel blockers for neuroprotection in multiple sclerosis.
Ontology highlight
ABSTRACT:
SUBMITTER: Yang C
PROVIDER: S-EPMC9242538 | biostudies-literature | 2015 Oct
REPOSITORIES: biostudies-literature
Publications
Sodium channel blockers for neuroprotection in multiple sclerosis.
The Cochrane database of systematic reviews 20151021 10
<h4>Background</h4>Multiple sclerosis (MS) is an autoimmune, inflammatory, demyelinating disease of the central nervous system (CNS), which can occur in many parts of the CNS and result in a wide range of symptoms including sensory impairment, fatigue, walking or balance problems, visual impairment, vertigo and cognitive disabilities. At present, the most commonly used MS treatments are immunomodulating agents, but they have little effect on the disability. Experimental studies show that sodium ...[more]
